13F-HR filed by Sio Capital Management, LLC
Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 51 holding rows worth $335,844,749.
- Accession
- 0001214659-24-009242
- Filer
- CIK 1482416
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 51 entries on the cover page, a total value of $335,844,749 stated on the cover page (in dollars after the unit check, H1), rows summing to $335,844,749 with VALUE read as dollars as filed, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 225,902 | $49,350,551 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,362,700 | $36,970,051 | dollars as filed | put |
| Cigna Corporation | 125523100 | COM | 76,086 | $27,633,674 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 393,420 | $21,103,049 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 51,000 | $13,619,040 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 263,445 | $11,293,887 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 74,179 | $9,790,144 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 105,000 | $9,150,750 | dollars as filed | |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 479,023 | $9,005,632 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 535,741 | $8,786,152 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 970,800 | $8,455,668 | dollars as filed | put |
| EMBECTA CORP | 29082K105 | COMMON STOCK | 585,418 | $7,768,497 | dollars as filed | |
| TELEFLEX INCORPORATED | 879369106 | COM | 33,878 | $7,662,187 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 635,969 | $6,302,453 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 203,174 | $6,282,140 | dollars as filed | |
| HUMACYTE INC | 44486Q103 | COM | 2,000,000 | $6,220,000 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 87,354 | $6,038,782 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 410,267 | $5,774,508 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 536,163 | $5,479,586 | dollars as filed | |
| HEALTHCARE SVCS GROUP INC | 421906108 | COM | 421,317 | $5,258,036 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 78,000 | $5,183,100 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 243,035 | $5,181,506 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 2,427,184 | $4,999,999 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 3,588,427 | $4,987,914 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 1,336,231 | $4,863,881 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 273,720 | $4,861,267 | dollars as filed | |
| INTEGRA LIFESCIENCES HLDGS C | 457985208 | COM NEW | 137,000 | $4,856,650 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 383,026 | $3,485,537 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 1,598,590 | $3,484,926 | dollars as filed | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 112,000 | $3,272,640 | dollars as filed | put |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 177,004 | $3,090,490 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 225,496 | $3,044,196 | dollars as filed | |
| MODULAR MED INC | 60785L207 | COM NEW | 1,539,352 | $2,847,801 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 315,000 | $2,828,700 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 468,871 | $2,306,845 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 378,000 | $2,079,000 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 143,000 | $2,037,750 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 276,603 | $1,850,474 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 163,363 | $1,542,147 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 320,394 | $1,518,668 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 33,007 | $1,448,347 | dollars as filed | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 149,400 | $1,301,274 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 121,672 | $816,419 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 50,839 | $685,818 | dollars as filed | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 102,049 | $516,368 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 130,000 | $289,900 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 10,151 | $220,784 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R200 | SPON ADS NEW | 254,150 | $156,353 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 400,000 | $109,880 | dollars as filed | |
| Humacyte Inc W Exp 08/27/202 | 44486Q111 | SPAC Combination | 49,998 | $31,026 | dollars as filed | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 12,808 | $302 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-24-009242 | this filing | 2024-05-15 | acceptance time not in the bulk data set |